首页> 外文会议>Annual meeting exposition of the Controlled Release Society >Pharmacological availability of orally administered insulin insulin-loaded gelatin nanoparticles in diabetic rats
【24h】

Pharmacological availability of orally administered insulin insulin-loaded gelatin nanoparticles in diabetic rats

机译:口服胰岛素胰岛素胰岛素胰岛素胰岛素胰岛素含有糖尿病大鼠的药理可用性

获取原文

摘要

Biologically and conformationally stable I insulin nsulin- loaded gelatin nanoparticles (NPs) were prepared and evaluated as a vehicle for the oral delivery of insulin in diabetic rats. Results show that at 50 IU/kg dose, orally t delivered insulin insulin-loade loaded NPs d lowered basal blood gluco glucose se levels in diabetic rats by 37 % and sustained hypoglycemia for over 12 h. Pha Pharmacological availability macological (PA) was 6.1 %, a significant increase over 1.4 % determined for oral insulin alone in solution. Encapsulation of in insulin into gelatin NPs sulin was observed to be a key factor in the improved bioavailability over insulin solution.
机译:制备生物学和综合稳定的I胰岛素胰蛋白加载的明胶纳米颗粒(NPS),并评估为糖尿病大鼠胰岛素口服递送的载体。结果表明,在50 IU / kg剂量下,口服胰岛素胰岛素 - 松开的NPS D降低了糖尿病大鼠的基础血液葡萄糖SE水平,持续37%和持续的低血糖超过12小时。 PHA药理学可用性MACOLOGY(PA)为6.1%,在溶液中仅针对口服胰岛素的1.4%显着增加。观察到胰岛素中的胰岛素中的胰岛素的封装是在胰岛素溶液中提高生物利用度的关键因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号